SCHEMBL8019019

SCHEMBL8019019

CC(=O)Oc1ccc(C=CC(=O)OC[C@@H](C(=O)O)N(C)C(=O)C=Cc2ccc(OC(C)=O)c(OC(C)=O)c2)cc1OC(C)=O

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 12/20 0.54
KDM4E B2RXH2 2/20 0.49
MAPT P10636 2/20 0.49
HTT P42858 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
JAK2 O60674 1/20 0.49
ALDH1A1 P00352 1/20 0.49
GAA P10253 1/20 0.49
JUN P05412 1/20 0.46
NFKB1 P19838 1/20 0.46
GLA P06280 1/20 0.46
RECQL P46063 1/20 0.46
AKR1C3 P42330 1/20 0.44
AKR1C2 P52895 1/20 0.44
BCHE P06276 1/20 0.42
MAOA P21397 1/20 0.42
ACHE P22303 1/20 0.42
MAOB P27338 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8030403 1.00 ALOX5 (0.54) ALOX5KDM4EMAPTHTTSMN1; SMN2
SCHEMBL8019021 1.00 ALOX5 (0.54) ALOX5KDM4EMAPTHTTSMN1; SMN2
SCHEMBL8028622 0.94 ALOX5 (0.56) ALOX5KDM4EMAPTHTTSMN1; SMN2
SCHEMBL8028826 0.80 ALOX5 (0.58) ALOX5KDM4EMAPTHTTSMN1; SMN2
SCHEMBL8030390 0.80 JUN (0.52) ALOX5KDM4EMAPTHTTSMN1; SMN2
SCHEMBL8028618 0.80 JUN (0.52) ALOX5KDM4EMAPTHTTSMN1; SMN2
SCHEMBL8030386 0.80 JUN (0.52) ALOX5KDM4EMAPTHTTSMN1; SMN2
SCHEMBL8028615 0.80 JUN (0.52) ALOX5KDM4EMAPTHTTSMN1; SMN2
SCHEMBL8029524 0.80 JUN (0.52) ALOX5KDM4EMAPTHTTSMN1; SMN2
SCHEMBL8029521 0.80 JUN (0.52) ALOX5KDM4EMAPTHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000063152-A1 ACETYLATED AND RELATED ANALOGUES OF CHICORIC ACID AS HIV INTEGRASE INHIBITORS THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2000-10-26 WO disclosed